Search - tctmd.com

Displaying 1 - 20 of 127

Sort: Relevancy | Date

News Daily News

CMS Greenlights Reimbursement for Renal Denervation Systems

L.A. McKeown

October 29, 2025

News Daily News

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

L.A. McKeown

October 09, 2025

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Daily News

CMS Issues Proposed Coverage Decision for Renal Denervation

Todd Neale

July 11, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Daily News

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Todd Neale

August 23, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

Michael O'Riordan

June 25, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

Advertisement

CMS Greenlights Reimbursement for Renal Denervation Systems

Slight Gain in Stroke Protection Seen With DAPT in ViV TAVI

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

CMS Issues Proposed Coverage Decision for Renal Denervation

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Top Structural Heart News of 2024

Top Endovascular News of 2024

Top Coronary Artery Disease News in 2024

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Study Supports Cost-effectiveness of Renal Denervation for Hypertension

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Weight-Loss Drug Tirzepatide Reduces Severity of Obstructive Sleep Apnea

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

FDA Approves Bioresorbable Scaffold for BTK Lesions

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

Top General Cardiology and CVD Prevention News of 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content